Literature DB >> 18294099

Tumour-immune cell interactions modulated by chemokines.

Karin Jöhrer1, Lisa Pleyer, Angelika Olivier, Eva Maizner, Claudia Zelle-Rieser, Richard Greil.   

Abstract

BACKGROUND: Chemokines are involved in almost all aspects of tumour establishment and progression.
OBJECTIVE: This review gives an insight into the complexity of chemokines and chemokine signalling in tumours, especially focusing on the tuning of the immune system within the tumour microenvironment.
METHODS: Experimental evidence from manipulation of the chemokine network in murine models and in vitro data are critically discussed, and the current status and potential future interventions therapeutically targeting chemokines for efficient and long-lasting tumour control in cancer patients are described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294099     DOI: 10.1517/14712598.8.3.269

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  22 in total

1.  The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.

Authors:  Cheng Peng; Keliang Zhou; Sensheng An; Jie Yang
Journal:  Tumour Biol       Date:  2014-09-26

Review 2.  The integrative roles of chemokines at the maternal-fetal interface in early pregnancy.

Authors:  Mei-Rong Du; Song-Cun Wang; Da-Jin Li
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

3.  CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.

Authors:  Yongqian Chen; Ye Tian; Zhengguo Ji; Zhi Liu; Donghao Shang
Journal:  Tumour Biol       Date:  2015-02-15

4.  An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population.

Authors:  Xing Gu; Hao Wang; Aihua Wang; Tonghai Dou; Peng Qi; Qiang Ji; Hui Li; Chunfang Gao
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

5.  STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.

Authors:  Chanyu Yue; Shudan Shen; Jiehui Deng; Saul J Priceman; Wenzhao Li; Austin Huang; Hua Yu
Journal:  Cancer Immunol Res       Date:  2015-05-29       Impact factor: 11.151

6.  TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity.

Authors:  Degui Geng; Sabina Kaczanowska; Alexander Tsai; Kenisha Younger; Augusto Ochoa; Aaron P Rapoport; Sue Ostrand-Rosenberg; Eduardo Davila
Journal:  Cancer Res       Date:  2015-03-20       Impact factor: 12.701

7.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.

Authors:  Martin Augsten; Christina Hägglöf; Eleonor Olsson; Claudia Stolz; Panagiotis Tsagozis; Tetyana Levchenko; Mitchell J Frederick; Ake Borg; Patrick Micke; Lars Egevad; Arne Ostman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

9.  Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.

Authors:  Rajesh Kumar Sharma; Zinal Chheda; Venkatakrishna Rao Jala; Bodduluri Haribabu
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

10.  Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo.

Authors:  Weilin Wang; Pengfei Huang; Lufei Zhang; Jianfeng Wei; Qingsong Xie; Qiang Sun; Xiaohu Zhou; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Cancer Sci       Date:  2013-10-14       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.